Cargando…
Advances in the Development of Antiviral Compounds for Rotavirus Infections
Group A rotaviruses (RVAs) are the major cause of severe acute gastroenteritis (AGE) in children under 5 years of age, annually resulting in nearly 130,000 deaths worldwide. Social conditions in developing countries that contribute to decreased oral rehydration and vaccine efficacy and the lack of a...
Autores principales: | Tohmé, María Julieta, Delgui, Laura Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262868/ https://www.ncbi.nlm.nih.gov/pubmed/33975930 http://dx.doi.org/10.1128/mBio.00111-21 |
Ejemplares similares
-
Advances in the development of antivirals for rotavirus infection
por: Jiang, Lin, et al.
Publicado: (2023) -
Role of sialic acids in rotavirus infection
por: Isa, Pavel, et al.
Publicado: (2006) -
Re-Examining Rotavirus Innate Immune Evasion: Potential Applications of the Reverse Genetics System
por: Antia, Avan, et al.
Publicado: (2022) -
The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs
por: Li, Yanbai, et al.
Publicado: (2023) -
Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
por: Gadiparthi, Chiranjeevi, et al.
Publicado: (2018)